1BORTHWICK E, FERGUSON A. Perioperative acute kidney in- jury: risk factors, recognition, management and outcomes[J]. BMJ,2010, 341: c3365.
2KOCOGLU H, OZTURK H, OZTURK H, et al. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study[J]. Ren Fail, 2009, 31(1): 70-74.
3CAROLLO D S, NOSSAMAN B D, RAMADHYANI U. Dexmedeto- midine: a review of clinical applications[J]. Curr Opin Anaesthe- siol, 2008, 21(4): 457-461.
4DJUDJAJ S, CHATZIANTONIOU C, RAFFETSEDER U, et al. Notch-3 receptor activation drives inflammation and fibrosis fol- lowing tubulointerstitial kidney injury[J]. J Pathol, 2012, 228(3): 286-299.
5DAEMEN M A, DE VRIES B, BUURMAN W A. Apoptosis and inflammation in renal reperfusion injury[J]. Transplantation, 2002, 73(11): 1693-1700.
6HUANG Y, RABB H, WOMER K L. Ischemia-reperfusion and immediate T cell responses[J]. Cell Immunol, 2007, 248(1): 4-11.
7THURMAN J M. Triggers of inflammation after renal ischemi- a/reperfusion[J]. Clin Immunol, 2007, 123(1): 7-13.
8BILLINGS F T, CHEN S W, KIM M, et al. Alpha2-adrenergic agonists protect against radiocontrast-induced nephropathy in mice[J]. Am J Physiol, 2008, 295(3): 741-748.
9STRAVODIMOS K G, KORITSIADIS G, LAZARIS A C, et al. Hydronephrosis promotes expression of hypoxia-inducible factor 1 alpha[J]. Urol Int, 2009, 82(1): 38-42.
10HAUCK I, HANSMANN, DIETZ R, et al. Inhibition of hypox- is-induced apoptosis by modulation of retinlblastoma pro- tein-dependent signaling in cardiomyocytes[J]. Cire Res, 2002, 91(9): 782-789.
